Moneycontrol PRO
LAMF
LAMF

Gvk Biosciences

Jump to
  • Goldman Sachs Private Equity emerges frontrunner to acquire ChrysCap stake in GVK Biosciences

  • Homegrown PE fund ChrysCapital exploring stake sale in GVK Biosciences

  • 'India waiting for EU's confirmation to proceed on FTA talks'

  • Drug applications based on Semler's data unacceptable: USFDA

  • Will submit clarification to EMA on clinical study data:Alkem

  • India keen to re-engage with EU on stalled FTA talks: Nirmala

  • India engaging with EU to sort out pharma issues: Govt

  • India, EU officials to meet tomorrow on FTA

  • FIPB clears 3 FDI proposals worth Rs 160 cr

  • India interested in reviving FTA talks with EU: Sitharam

  • EU ban on GVK-tested drugs a 'great concern': Sitharaman

  • India, EU working to end trade huff over generic drugs

  • India defers FTA talks with EU over ban of pharma products

  • EU bans 700 generic drugs for manipulation of trials by GVK

  • GVK Bio, Akaal extend partnership for drug development

  • Swedish pharma firm partners GVK Bio for drug research

  • German regulator hails EMA's drugs suspension on GVK Bio

  • GVK Biosciences, Onconova ink pact to develop cancer drugs

    Contract research organisation GVK Biosciences has inked a pact with US-based Onconova Therapeutics to develop new drugs for treatment of cancer.

  • No proof of GVK drug trials going awry: DL Reddy

    Andhra Pradesh health minister DL Ravindra Reddy said that there is no evidence to prove the participation of GVK Bio Sciences and the investigations are being carried on to punish the guilty.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347